Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche dives further into cancer cell therapy with Adaptimmune deal
Pharmaforum
Tue, 09/7/21 - 10:57 am
Tags:
Roche, cell therapy, cancer, Adaptimmune Therapeutics
Roche, hoping to move on from recent failure, pens $190M NeuExcell Huntington's disease pact
Fierce Biotech
Tue, 09/7/21 - 10:55 am
Tags:
Roche, Huntington's disease, NeuExcell
Roche to withdraw US accelerated approval for Tecentriq to treat breast cancer
Pharmaceutical Business Review
Mon, 08/30/21 - 10:42 am
Tags:
Roche, Tecentriq, Abraxane, triple negative breast cancer, FDA, accelerated approval
Roche pulls Tecentriq breast cancer nod after post-approval trial flop
Fierce Pharma
Sat, 08/28/21 - 09:04 pm
Tags:
Roche, Tecentriq, breast cancer, triple negative breast cancer, postmarketing studies
Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's
BioSpace
Tue, 08/24/21 - 11:12 am
Tags:
Roche, Shape Therapeutics, RNA editing, RNAfix, Alzheimer's disease, Parkinson's Disease
Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage
Benzinga
Tue, 08/17/21 - 10:16 am
Tags:
Roche, Actemra, COVID-19, drug shortages
J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report
Fierce Pharma
Thu, 08/12/21 - 11:04 pm
Tags:
JNJ, Amgen, Roche, biosimilars, drug pricing
Roche sets bar in early lymphoma treatment with Polivy study results
BioPharma Dive
Tue, 08/10/21 - 11:23 pm
Tags:
Roche, Polivy, lymphoma
On a quest to treat newly diagnosed lymphoma patients, Roche teases positive pivotal data
Endpoints
Mon, 08/9/21 - 11:07 am
Tags:
Roche, Polivy, diffuse large B-cell lymphoma
FDA starts review of Roche’s eye disease drug, setting up 2022 verdict
Pharmaforum
Thu, 07/29/21 - 10:57 pm
Tags:
Roche, faricimab, bispecific antibodies, diabetic macular edema, wet age-related macular degeneration
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Motley Fool
Thu, 07/29/21 - 11:12 am
Tags:
AbbVie, Roche, Venclexta, MDS, breakthrough therapy
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Pharmaforum
Thu, 07/22/21 - 11:05 am
Tags:
Roche, FDA, Alzheimer's disease, gantenerumab
Roche takes the Tim-3 battle to Novartis
EP Vantage
Thu, 07/22/21 - 10:53 am
Tags:
Roche, sabatolimab, Novartis, RG7769, bispecific antibodies
AbbVie, Roche top data transparency list, but more could be done to build trust in medical system: report
Fierce Biotech
Wed, 07/21/21 - 10:56 am
Tags:
clinical trials, clinical trial transparency, AbbVie, Roche
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Tags:
Novartis, AbbVie, GSK, Roche, Eli Lilly, AstraZeneca, FDA, drug launches, drug approvals
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Motley Fool
Sun, 07/11/21 - 11:13 pm
Tags:
clinical trials, Novartis, Biogen, SAGE Therapeutics, uniQure, Pfizer, Roche
bluebird bio Responds to Marketing Campaign Lawsuit with Countersuit
BioSpace
Wed, 07/7/21 - 10:25 pm
Tags:
pharma marketing, Bluebird Bio, Spark Therapeutics, Roche
WHO signs off on IL-6 drugs to treat severe Covid-19 cases, reigniting pricing debate
Endpoints
Wed, 07/7/21 - 10:55 am
Tags:
WHO, COVID-19, IL-6, Sanofi, Kevzara, Roche, Actemra
Roche to seek early FDA approval for Alzheimer’s therapy: Jefferies
Seeking Alpha
Thu, 07/1/21 - 10:45 am
Tags:
Roche, FDA, Alzheimer's disease, gantenerumab
Roche confirms it could cut 300 to 400 product development jobs
Fierce Biotech
Thu, 07/1/21 - 10:42 am
Tags:
Roche, layoffs, product development, Switzerland

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.